ProShare Advisors’s Zai Lab ZLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-5,855
Closed -$200K 1895
2022
Q3
$200K Buy
+5,855
New +$251K ﹤0.01% 1413
2022
Q2
Sell
-7,312
Closed -$322K 2160
2022
Q1
$322K Sell
7,312
-2,571
-26% -$124K ﹤0.01% 1579
2021
Q4
$621K Sell
9,883
-4,934
-33% -$418K ﹤0.01% 1310
2021
Q3
$1.56M Buy
14,817
+3,786
+34% +$544K ﹤0.01% 775
2021
Q2
$1.95M Buy
11,031
+2,771
+34% +$446K 0.01% 731
2021
Q1
$1.1M Sell
8,260
-336
-4% -$52K ﹤0.01% 931
2020
Q4
$1.16M Sell
8,596
-281
-3% -$28.6K ﹤0.01% 814
2020
Q3
$738K Buy
8,877
+315
+4% +$25.3K ﹤0.01% 804
2020
Q2
$703K Buy
8,562
+3,438
+67% +$233K ﹤0.01% 810
2020
Q1
$264K Sell
5,124
-2,915
-36% -$152K ﹤0.01% 918
2019
Q4
$334K Sell
8,039
-1,399
-15% -$51.6K ﹤0.01% 1277
2019
Q3
$305K Buy
9,438
+3,148
+50% +$108K ﹤0.01% 1224
2019
Q2
$219K Sell
6,290
-770
-11% -$22.7K ﹤0.01% 1388
2019
Q1
$208K Buy
+7,060
New +$193K ﹤0.01% 1454

Other funds holding ZLAB

ProShare Advisors's ZLAB Position: Q4 2022 in Review

ProShare Advisors sold out of Zai Lab (ZLAB) in Q4 2022, closing a stake of 5,855 shares — an estimated $200K sold.

ProShare Advisors first reported a position in ZLAB in Q1 2019 and held it in 14 quarters. The position peaked at $1.95M in Q2 2021. 166 funds tracked by Wall St. Rank hold ZLAB as of Q4 2022.

  • ProShare Advisors reported no remaining Zai Lab position as of Q4 2022 after selling out during the quarter.
  • ProShare Advisors sold 5,855 Zai Lab shares in Q4 2022, an estimated $200K.
  • ProShare Advisors first reported a position in Zai Lab in Q1 2019 and held it in 14 quarters.
  • ProShare Advisors's Zai Lab position peaked at $1.95M in Q2 2021.
  • 166 funds tracked by Wall St. Rank held Zai Lab as of Q4 2022.

Based on ProShare Advisors's 13F filing for Q4 2022, filed 2 Feb 2023.